In this study, we report the AML mutation landscape for this patient as determined by total RNA-seq (Supplementary Table S3), which revealed heterozygous mutations in FANCA at c.3779T>C (p.L1260P) and the FA-associated gene FANCD2 and FANCI-associated nuclease 1 (FAN1) at c.2435G>A (p.C812Y). The gene discussed is FANCD2; the disease is acute myeloid leukemia.